American Association for Cancer Research

April 16–20, 2016 | Ernest N. Morial Convention Center, New Orleans, LA

Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. At Fluidigm, we are focused on providing research solutions to help you interrogate the tumor microenvironment, blood-based cancers, and immune cell function with unprecedented resolution. From Helios™ mass cytometry and Maxpar® antibody panels that allow you to obtain high-dimensional immune phenotypes to single-cell genomics solutions that provide a comprehensive view of the tumor microenvironment, we can help you reach your next breakthrough.

Visit Fluidigm at Booth 2356

Exhibit Dates & Hours:

  • Sunday, April 17: 1:00–5:00 pm
  • Monday, April 18: 9:00 am–5:00 pm
  • Tuesday, April 19: 9:00 am–5:00 pm
  • Wednesday, April 20: 9:00 am–12:00 pm

Product Presentations

Complete end-to-end single-cell workflows and targeted next generation sequencing solutions from Fluidigm allow you to examine both cancer cells and immune cells from every angle.

Helios, a CyTOF® System

Identify immune signatures using single-cell proteomic profiling

 Helios

C1™

Reveal the tumor microenvironment at single-cell resolution.

 

Polaris™

Explore cancer cell function at the single-cell level.

 Polaris

Juno™

Simplify targeted NGS library prep, gene expression and genotyping of genes related to tumor progression.

 Juno

2016 AACR Posters Featuring Fluidigm Technology & Presentations of Interest

Saturday, April 16

Time

Title

Presenting Author & Institution

Abstract #
Poster #

Location

10:45–11:10 am The many faces of circulating tumor cells James Hicks,
University of Southern California
Room 265
11:45 am–12:10 pm Single cell transcriptomics and its application to cellular phenotyping of primary tumors Paul Robson,
The Jackson Laboratory
Room 265
1:00–1:25 pm Leukemic stem cells lie at the origin of AML relapse John Dick,
University of Toronto
Room 265

3:15–3:35 pm

Highly multiplexed imaging of tumor tissues by mass cytometry for precision medical applications

Bernd Bodenmiller, University of Zurich

New Orleans Theater B

4:15–4:35 pm Integrated (epi)genome and transcriptome sequencing from single cells: principles and applications in cancer Ian C. Macaulay, Wellcome Trust Sanger Institute
New Orleans Theater B

Sunday, April 17

Time

Title

Presenting Author & Institution

Abstract #
Poster #

Location

7:00–8:00 am

Making the most of single-cell RNAseq data

Dana Pe’er,
Columbia University

Room 354

1:00–5:00 pm

Identification of the carcinoma and immune cells in the breast cancer by single-cell RNA sequencing

Woosung Chung,
Samsung Genome Institute, Seoul, Korea

160/14

Section 6

Single-cell RNA sequencing presents explicit expression signatures in primary breast cancer

Hye Hyeon Eum,
Samsung Genome Institute, Seoul, Korea

161/15

Section 6

Monday, April 18

Time

Title

Presenting Author & Institution

Abstract #
Poster #

Location

8:00 am–12:00 pm

A systems immunology analysis to detect prognostic biomarkers in patients with squamous cell carcinomas of the head and neck

Cariad Chester,
Stanford University

1401/2

Section 22

Molecular subtypes of breast cancers and normal mammary epithelial cells show hierarchical heterogeneity and complexity at single-cell resolution

Ebrahim Azizi,
University of Michigan

1585/2

Section 30

Epithelial mesenchymal transition generates cancer stem cells in CD44- colorectal cancer cells

Michitaka Nakano,
Kyushu University, Fukuoka City, Japan

1707/4

Section 34

The role of CD44v9+ colorectal cancer stem cells in the resistance to cetuximab treatment

Chia-Nung Hung,
Tunghai University, Taichung, Taiwan

1716/13

Section 34

1:005:00 pm

Comprehensive RNA-seq transcriptome interrogation of paired hepatocellular carcinoma and cirrhosis tissues revealed significant molecular features of disease evolution and modulation of tumor immunity

Bonnie P. Liu,
Genentech, South San Francisco

1837/5

Section 3

Single-cell multiplexed profiling of protein-level changes induced by EGFR inhibitor gefitinib

Ilona Holcomb,
Fluidigm

1853/21

Section 3

Simultaneous profiling of mRNA and protein in single human induced pluripotent stem cells Benjamin Liu,
Flluidigm
LB-147/1 Section 10

The immune modulatory roles of IAP inhibitor, LCL161, and its connection to immune-checkpoint molecules

Maria Pinzon-Ortiz,
Novartis Cambridge

2343/27

Section 26

The polyclonal nature of multinodular goitre revealed by DICER1 sequencing

Leanne de Kock,
Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; McGill University, Montreal

2390/20

Section 28

3:353:50 pm

In depth immune profiling of the response of melanoma to MAPK inhibition

Sarah J. Welsh,
Macquarie University, Sydney, Australia

2650

Theater B

3:504:05 pm

Relapse in BCP-ALL predicted by activated signaling in pro-B cell subsets

Zinaida Good,
Stanford University

2693

Room 354

Tuesday, April 19

Time

Title

Presenting Author & Institution

Abstract #
Poster #

Location

8:00 am–12:00 pm

Expression of CD14 and SIRP-α defines distinct populations of intratumoral monocytes/macrophages in B-cell non-Hodgkin lymphomas

Ya-Ping Chen,
Mayo Clinic, Rochester, MN

3287/7

Section 29

Riboflavin targets autofluorescent-positive breast cancer stem cells upon light exposure

Shamileh Fouladdel, University of Michigan

3310/8

Section 31

Single-cell analysis reveals molecular mechanisms of NRAS-mediated leukemia stem cell self-renewal in a murine model of AML

Rebecca S. LaRue, University of Minnesota

3339/7

Section 32

1:005:00 pm

Single cell dual adherent-suspension co-culture microenvironment for studying tumor-stromal interactions in breast cancer stem cells

Yu-Chih Chen,
University of Michigan

4076/3

Section 29

Circulating vitamin D2 and D3 levels and single nucleotide polymorphism associations with lung cancer status: a case-control study

Majda Haznadar,
National Cancer Institute, Bethesda

4320/11

Section 37

Gene expression and genomic drift comparative analysis between patient-derived conditionally reprogrammed cells and original tumors

Jessica Li,
Genentech, South San Francisco

4257/7

Section 35

Wednesday, April 20

Time

Title

Presenting Author & Institution

Abstract #
Poster #

Location

7:30–11:00 am

Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit (IFC) for functional single cell studies

Lukasz Szpankowski
Fluidigm

5035A/30

Section 27

8:00 am
12:00 pm

Intratumoral HPV16-specific T-cells determine clinical outcome of HPV16+ oropharyngeal carcinomas

Marij J. Welters,
Leiden University Medical Center, Leiden, Netherlands

5035A/30

Section 27

Social Media

Can’t make it to all of the sessions? Follow @fluidigm with #AACR16 and like us on Facebook for scientific and event updates.